Featured Blogs
On July 22, 2026, the Senate Health, Education, Labor, and Pensions (HELP) Committee held an executive session to consider health care legislation including three bills aimed at increasing price transparency and improving workforce shortages. Those bills were batched together and were agreed to, as amended, by a roll call vote of 21-1, with Sen. Rand Paul (R-KY) voting no. Please see below for a description of each of those bills, any notable discussion, and amendments considered.
OPENING STATEMENTS
SELECT LEGISLATION ADVANCED IN THE MARKUP
S. 2355, Patients Deserve Price Tags Act (Sen. Roger Marshall (R-KS), Sen. John Hickenlooper (D-CO), and Sen. Maggie Hassan (D-NH)), to enforce health care price transparency by requiring hospitals, labs, and surgical centers to publish upfront, actual dollar amounts for services.
- Sen. Paul shared his view that the problem is that prices are fixed by insurers (either government or private) and simply publicizing prices won’t change them.
S. 4110, EMPOWER for Health Act (Sen. Jack Reed (D-RI) and Sen. Lisa Murkowski (R-AK)), to reauthorize Title VII health professions workforce development programs through FY2030 to address medical provider shortages and diversify the health care workforce.
- Sen. Lisa Blunt Rochester (D-DE) offered an amendment to give the Health Resources Services Administration (HRSA) the authority to create a federal nursing data collection center.
- The amendment passed by voice vote.
S. 1847, Title VIII Nursing Workforce Reauthorization Act (Sen. Jeff Merkley (D-OR)) to reauthorize HRSA nursing education through federal funding and expanded access to clinical training in underserved areas.
- Sen. Blunt Rochester offered an amendment to establish a state and regional nursing workforce center data collection pilot program.
- The amendment passed, with Sen. Paul recorded as nay.
- Sen. Murkowski offered an amendment to provide for a wage differential program to support new nursing school faculty members.
- The amendment passed, with Sen. Paul and Sen. Alan Armstrong (R-OK) recorded as nay.
Most Medicaid proposals on long-term services and supports (LTSS) carry an unstated assumption that the primary users of LTSS are older adults aging in place. In reality, many others use LTSS including individuals with Intellectual and Developmental Disabilities (IDD), Serious Mental Illness (SMI), Traumatic Brain Injury (TBI), and children with complex medical needs.
The people who rely on LTSS don’t fit neatly into one box. Each group has unique needs and policymakers face distinct challenges in meeting those needs, and are all navigating a Medicaid system under significant pressure. This blog looks at four of these subpopulations, what they need, and what’s standing in the way.
Background on LTSS
LTSS care is largely provided through Medicaid coverage that is a mix of institutionalization and home- and community-based services (HCBS). HCBS was not originally written into Medicaid policy, which has led to gaps across states and policies centered around only older adults, primarily people aged 65 and older who need help with daily activities due to age-related decline.
People with Intellectual and Developmental Disabilities (IDD)
People with IDD require a lifetime of support and face waiver waitlists that can last more than a decade, the longest delays of any LTSS subpopulation.
The One Big Beautiful Bill Act (OBBBA), signed into law July 4, 2025, created a new 1915(c) waiver category allowing states to serve individuals before they hit the institutional level-of-care (LOC) threshold, with $50M for FY26 and $100M for FY27. It sounds meaningful, but the math is less encouraging. According to an analysis using 2020 average per-capita HCBS spending, that $50M divided across 50 states covers roughly 27 people per state. The authority also doesn’t kick in until July 2028, and per-capita spending is capped at state institutional care rates, which limits how far states can go.
The real test of this new waiver authority is whether states use the next two years to build it into something impactful, a decision is being made in state budget offices right now.
People with Serious Mental Illness (SMI)
SMI impairments are episodic and cognitive, manifesting in the inability to consistently manage medications, maintain housing, or navigate a crisis. Standard LOC assessments were not built to capture that, so those who genuinely need support get turned away from care and cycle through ERs, jails, and shelters instead.
This is primarily a state-level problem as each state designs its own assessment instrument. Any state can adopt a more comprehensive tool that accounts for cognitive and episodic limitations, though budget neutrality requirements create a real constraint. On the federal side, H.R. 3320, the Strengthening Medicaid for SMI Act would increase the federal match for intensive community-based SMI services. It likely won’t pass this Congress, as there is only one cosponsor, there is no Senate bill, and the sponsor (Rep. Goldman (D-NY-10)) lost his re-election bid. However, it’s a clear marker of where reform is headed.
Children with Complex Medical Needs
Children with complex medical needs don’t automatically age out of their conditions at 19, but they can age out of the Medicaid coverage keeping them stable.
Many qualify for coverage through the Katie Beckett Program, created under the Tax Equity and Fiscal Responsibility Act (TEFRA) in 1982, which allows children with significant disabilities to access Medicaid regardless of family income. But the transitions out of pediatric coverage are a gauntlet and lead to a potential break in coverage due to the long waiver waitlists and inconsistent requirements.
The Medicaid and CHIP Payment and Access Commission’s (MACPAC) June 2026 report to Congress includes a chapter on this problem. The Commission provided recommendations, including requiring states to send advance notice of aging and implementing a 12-month continuous eligibility to account for waiting time. The chapter provides a solid baseline for advocates to influence congressional action.
People with Traumatic Brain Injury (TBI)
Around 5.3 million Americans live with a lifelong disability as a result of a brain injury; however, TBI-specific HCBS waivers exist in only about 20 states. In the rest, individuals are misclassified under other waiver categories or fall through the gaps entirely, ending up in shelters, jails, or ERs that aren’t equipped to help them.
CMS recognized TBI as a chronic condition in the Contract Year 2025 (CY25) Medicare Advantage and Part D Final Rule, a federal precedent advocates can point to when making the Medicaid parity argument. However, the more immediate action is at the state level as North Carolina, Maryland, and Nebraska are actively expanding TBI-specific waivers. For advocates in states without them, these are the types of models to bring to your state Medicaid director.
The Common Thread
Each of the subpopulations experiences the same blind spot: Medicaid HCBS was designed around, and for, older adults aging in place and then extended to other populations through inconsistent waivers and state amendments.
The direct care workforce shortage reflects the mismatch there are not enough caregivers to serve every population in need. Providers turn away over 25% of referrals due to staffing shortages. When formal care is unavailable, family members become caregivers and often leave the workforce to do so.
The fragmentation has confined each population to its own waiver structure, agency contact, and advocacy community. As a result, the four subpopulations are fighting the same underlying fight in isolation.
Most pressing of all, HCBS remains an optional Medicaid benefit rather than a guaranteed one, making it a prime target when states cut budgets. This means each of these subpopulations’ care is first to go if money gets tight.
Where to Go from Here
Just as these programs were built state by state, the policy levers to change them rest primarily with the states. IDD waiver implementation, SMI assessment redesign, and TBI waiver expansion are each determined at the state level. Only the children’s transition issue is squarely a federal ask, addressed through MACPAC recommendations and congressional action.
That means the most consequential near-term decisions are happening in state budget negotiations, as states absorb the fiscal pressure from OBBBA and decide what to implement with the new authorities it created.
That does not mean the federal level is quiet. On May 20, 2026, Senate Finance Committee ranking member Ron Wyden (D-OR) and 16 Senate Democrats issued a dear colleague letter signaling interest in policies to make long-term care more affordable and accessible for seniors and people with disabilities. Requests for Information comment periods, and staff briefings are all on the table as avenues to raise these populations’ visibility with congressional staff before legislative text is drafted.
These four populations are not fighting different battles. They are fighting one battle, alone, inside a system that was never built to hold them together. The workforce shortage, the optional status of HCBS, and the fragmentation of policy levers across fifty states are not separate problems. They are the same exclusion, appearing in different forms. As Congress and state legislatures shape the next round of Medicaid decisions, the populations with the most at stake have the least shared voice in the room. That imbalance needs to change before the decisions do.
Remember when you were a kid, and someone else’s school got out for summer before yours? That same deeply unfair feeling is settling over the Senate right about now. The House has packed its bags and headed home for summer break, while senators are still stuck at their desks watching their colleagues disappear into the sunshine while feeling the heat from the President on the SAVE Act. So, let’s get into it. Welcome to the Week Ahead!
The Administration
President Trump has announced his next set of tariffs on the pharmaceutical sector with a 100% tariff on imported generic drugs beginning in August 2028. John Murphy III, the President and CEO of the Association for Accessible Medicines (AAM)has said they need to see more specifics about the policy, but that the generics industry is committed to policies that stabilize the industry and patient access to affordable medications. On the Hill, Senate Finance Committee Ranking Member Ron Wyden (D-OR) introduced legislation to require congressional approval of tariffs before they take effect.
Attention is divided at the Centers for Disease Control and Prevention (CDC) as the agency deals with rising measles cases and the cyclosporiasis outbreak. Measles was declared eliminated in the US in 2000, but cases have been on the rise over the past few years. Over halfway through 2026, and the number of reported cases has surpassed 2025 levels, which was the most reported since 1991. Cyclosporiasis is also hitting new milestones as 9 states are now battling outbreaks. The Food and Drug Administration (FDA) is working with the CDC to investigate sources of the parasite and contain its spread. The simultaneous public health threats have fueled criticisms about public health funding levels and staffing cuts at the agencies. The lack of permanent leadership at the CDC and FDA is likely not helping the administration to contain the issues and will mean that any nominee will have a lot to clean up.
The Senate
The Senate must now pick up where the House left off and decide on the direction for Reconciliation 3.0. Senate Majority Leader John Thune (R-SD) has said he doesn’t have the votes to pass the House resolution and that his focus is on government funding. Thune has said that he plans to bring the House-passed continuing resolution (CR), which extends existing government funding through December 4, up for a vote before the Senate’s August recess. However, he has also said he would consider using Reconciliation to fund the government and avoid a shutdown if a CR cannot be passed. Notably, the CR does not include health care extenders, such as telehealth flexibilities and funding for Medicare-dependent and low-volume hospitals, that often accompany government funding bills because most of them are already extended until at least the end of the year.
Meanwhile, new Senate Budget Committee Chairman Ron Johnson (R-WI) shared that he has directed Budget Committee staff to begin drafting two Senate budget resolutions, with the goal to pass one of them before the August recess. The first would mirror the House resolution, and the second would be more expansive to ensure GOP funding priorities are met. Chairman Johnson also said he supports a fourth reconciliation package focused on addressing fraud. In discussing this, he cited Centers for Medicare and Medicaid Services actions against hospice providers in Los Angeles as an example of the sort of rampant fraud that needs to be addressed.
Also on our radar: Senate Health, Education, Labor, and Pensions (HELP) Committee Chairman Bill Cassidy (R-LA) is looking to move on the Committee vote to advance the nomination of Dr. Erica Schwartz to be Director of the Centers for Disease Control and Prevention (CDC). This vote had to be delayed, despite Cassidy’s support, due to a family emergency affecting Sen. Lisa Murkowski (R-AK). Along with Dr. Schwartz’s nomination, the Committee also delayed a vote on the nomination of Sean Kaufman to serve as Assistant Secretary for Preparedness and Response (ASPR). During his nomination hearing, bipartisan concerns were raised about his views on vaccines. A HELP Committee spokesperson has shared that “there are ongoing conversations with the administration on the path forward for Mr. Kaufman’s nomination.” The Committee is scheduled to vote on his nomination, as well as bill from Chairman Cassidy on health privacy, during the July 30 executive session.
Other Health Care Hearings This Week
- July 29: Senate Homeland Security Committee hearing with Dr. Anthony Fauci
The House
House Members are out of session until August 31.
There You Have It
What was your final week of school like when you were little? Field days, yearbook signings, class parties? Let us know your favorites! Make it a great week.
On July 20-21, 2026, the House Energy and Commerce Committee held a markup that included several pieces of legislation related to Medicare Advantage, health care price transparency, and illicit drugs. The Improving Seniors’ Timely Access to Care Act, along with several other bills, were incorporated by an amendment into the larger Lower Costs, More Transparency Act. All the bills passed unanimously, except for the Prices on the Wall Act. Democratic members of the Committee opposed this bill because of concerns that the bill’s requirements would cause confusion for patients and deter them from seeking care. You can see a list of select bills included in the markup below, along with any notable discussion and the vote tallies.
OPENING STATEMENTS
SELECT LEGISLATION INCLUDED IN THE MARKUP
H.R. 2004, Tyler’s Law (Reps. Ted Lieu (D-CA-36) and Robert Latta (R-OH-5)), to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose.
- The bill passed out of Committee by a vote of 46-0
H.R. 9390, the Prices on the Wall Act (Rep. Mariannette Miller-Meeks (R-IA-2)), to require hospitals, ambulatory surgical centers, and labs to post the discounted cash price in dollar amount on the wall for each service they provide.
- Ranking Member Pallone stated that while he supports price transparency, he has strong concerns that implementation of the bill will be impractical, will cause more confusion for patients, and will deter patients from seeking care. Ranking Member Pallone highlighted H.R. 9393, the Lower Costs, More Transparency Act, as a more useful approach to price transparency.
- The bill passed out of Committee by a vote of 24-21, along party lines, with Republicans voting for the bill and Democrats voting against it.
H.R. 9393, the Lower Costs, More Transparency Act of 2026 (Reps. Guthrie (R-KY-2) and Pallone (D-NJ-6)), to require hospitals, surgical centers, labs, and imaging providers to post prices and require health plans to disclose negotiated rates, cost-sharing estimates, and pharmacy benefit manager (PBM) spread pricing.
- Chairman Guthrie offered an amendment, which was adopted by voice vote, to include the following legislation as part of this bill:
- H.R. 9397, the Premium Transparency Act (Reps. August Pfluger (R-TX-11) and Nathanial Moran (R-TX-1)), to ensure health insurer accountability through publishing of overhead costs and claim payments.
- H.R. 9396, the Prior Authorization Accountability Act (Rep. Craig Goldman (R-TX-12)), to require insurers to display which services were subject to prior authorization, the percentage of requests approved or denied, and the average amount of time between the request submission and determination.
- H.R. 3514, Improving Seniors’ Timely Access to Care Act of 2025 (Reps. Mike Kelly (R-PA-16) and Suzan DelBene (D-WA-1)), to require plans to establish, and evaluate the implementation of, an electronic prior authorization.
- H.R. 9392, the Medicare Advantage Cost Transparency Act (Reps. Diana DeGette (D-CO-1) and John Joyce (R-PA-13)), to require the inclusion of certain information in Medicare Advantage encounter data.
- H.R. 5243, to require each Medicare Advantage plan to submit eligibility for supplemental benefits, types of benefit categories offered, and data on utilization of and payments for such benefits (Rep. Jennifer McClellan (D-VA-4)).
- The amendment pushed back dates for certain provisions within these bills. For example, the amendment changed the Improving Seniors’ Timely Access to Care Act so the prior authorization requirements would be in effect for any applicable item or service during a plan year beginning on or after January 1, 2029, instead of January 1, 2028, for the electronic prior authorization program and January 1, 2027, for the transparency requirements.
- Rep. Jake Auchincloss (D-MA-4) spoke positively of the amendment but requested that the Committee consider more pharmacy benefit manager (PBM) reforms.
- Rep. John James (R-MI-10) offered an amendment to include H.R. 5582, the Patients Deserve Price Tags Act, as he believes that would improve price transparency for consumers more than H.R. 9393. However, the amendment was withdrawn.
- The Lower Costs, More Transparency Act, as amended by Chairman Guthrie, was passed out of Committee by a vote of 45-0.